CYCS and Alzheimer disease: Together with reports on the neuroprotective role of the inhibition of Bax translocation or cytochrome C release in ischemia47 and Huntington’s disease48, our findings suggest that inhibiting Bax can be exploited as a potential therapeutic approach to alleviating neuronal loss in AD.